4
Changes in Ownership
Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-006741
Director acquired 5,542 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Velleca Mark A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-17 | Grant or award : show line 1 in the form | +5,542 | $2.03 | $11,250 | 8,439 | D |
Loading xslF345X03/form4-06172022_010656.xml…